REVIV launches IV Pro, empowering clinics to deliver trusted IV therapy worldwide

LONDON, UK – 23rd July 2025

REVIV Global, the leader in IV therapy and precision health, has launched IV Pro, a new digital platform that lets healthcare providers offer REVIV’s trusted IV therapies safely under their own brand. IV Pro brings the same trusted care and technology used at REVIV’s flagship clinics to providers worldwide.

IV Pro is designed for medical businesses that want to add IV therapy to their offerings without having to build their own systems, protocols, or products. Developed by REVIV’s team of medical experts, scientists, and software engineers, the platform is based on over ten years of clinical experience and data from more than three million treatments globally.

IV Pro is the first and only global platform combining bio and genomic data with AI-driven tools to deliver personalized IV nutrition therapy.
The platform combines three key tools to make IV therapy safe and easy to deliver:

• IV Formulate delivers personalised IV drips, creating over 26,000 options based on a client’s health and lifestyle.
• IV MediScreen reviews medical history and medications to ensure every treatment is safe.
• IV Academy offers a CME and CPD-accredited online training course that certifies healthcare professionals in IV therapy.

At the core of REVIV’s approach is a precision health ecosystem that uses genetic information to guide both precision supplements and precision IV therapies. The IV Pro platform sits at the heart of this ecosystem, powering REVIV and 10X’s key offerings, including REVIV X and 10X Decode, with more innovations to come.

IV Pro integrates directly with REVIV’s genetic test, developed in partnership with 10X Health, which analyzes DNA markers linked to nutrient absorption and detoxification. This integration enables the delivery of truly personalized wellness solutions based on each individual’s biology. By centralizing and enabling these precision tools, IV Pro plays a vital role in driving the future of personalized health.

Following its UK launch, REVIV is expanding IV Pro globally. The platform includes a subscription system and will soon connect with popular industry tools like Pabau, allowing quick setup and easy integration across clinics and wellness providers.

“When people think of REVIV, they often think of an IV clinic. But we are so much more than that,” said Sarah Lomas, CEO of REVIV Global. “Our technology isn’t just powering IV therapy: it’s laying the foundation for the entire precision health and wellness industry worldwide. This platform will enable brands across multiple sectors to deliver truly personalised care like never before. I’m incredibly proud of our teams and what they have built to drive this important growth.”

Erin Short, REVIV's Chief Product Officer, adds: “People say you can’t buy more time, I disagree. At REVIV, we’re building the technology that gives it back. We are on a mission to transform human health through cutting-edge personalized nutritional solutions. Behind this mission is IV Pro, a powerful B2B health platform transforming healthcare globally by enabling providers to deliver personalized, precision care with confidence."

REVIV has a network of over 100 clinics in 47 countries across four continents. This figure includes partner clinics who operate under their own brand name.

For more information, visit www.ivpro.com.

For media enquiries, contact press@revivme.com